50
Pharma & HealthcareHold
ABSL Pharma And Healthcare
Aditya Birla Sun Life · Direct–Growth · rank #10 of 18 by Smart Score
Trailing returns
1 Year
14.9%
+14.3% vs index
3 Years
23.6%
+11.4% vs index
5 Years
14.5%
+2.6% vs index
Since launch
21.5%
Year-by-year performance
2021
+21.4%-9.3% vs index
2022
-11.3%-15.1% vs index
2023
+39.6%+13.0% vs index
2024
+37.7%+22.0% vs index
2025
-3.1%-10.8% vs index
2026
+16.6%+18.3% vs index
Why this score
ABSL Pharma And Healthcare scores 50/100 — #10 of 18 Pharma & Healthcare fund (Hold). It stands out for sortino ratio and sharpe ratio — beating 78% of peers on sortino ratio. The main drag is its 5y return (better than only 28% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
5Y return14.54% · 28th percentile in category
Sortino ratio1.92 · 78th percentile in category
Sharpe ratio1.15 · 62nd percentile in category
Alpha3.06 · 32nd percentile in category
1Y return14.86% · 74th percentile in category
3Y return23.60% · 55th percentile in category